Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 23, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
On June 22, 2005, the GlaxoSmithKline Employee Trust ("the GSK Trust") transferred 12,338 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on June 23, 2005.
Outlook, Risks, and Management Commentary
The filing contains no guidance, outlook, management commentary, risks, contingencies, or unusual items. It strictly details the mechanics of the share transfer and notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) are interested in the shares held in the GSK Trust as potential beneficiaries alongside other employees.
Key Facts for Investor Verification
- 12,338 Ordinary Shares were transferred from the GSK Trust to employee plan participants on June 22, 2005.
- Three directors hold an interest in the GSK Trust as potential beneficiaries.
- This filing does not include financial results or operational updates for the period.